CALL                                                                                                                      ...
Conference Introduction                                                        2nd Pharmaceutical Anti-counterfeiting Amer...
Day 1                                                           2nd Pharmaceutical Anti-counterfeiting Americas           ...
Day 2                                                           2nd Pharmaceutical Anti-counterfeiting Americas           ...
Partners                                                                 2nd Pharmaceutical Anti-counterfeiting Americas  ...
Registration Form                                                                       2nd Pharmaceutical Anti-counterfei...
Upcoming SlideShare
Loading in …5

2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp


Published on

Email for early bird discount

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

2nd Pharmaceutical Anti Counterfeiting Americas (2011) Pp

  1. 1. CALL NOW FOR EARLY BIRD 2nd Pharmaceutical DISCOUNTS Anti-counterfeiting Americas Debate the best practices in combating counterfeit medicines November 14th – 15th 2011, Boston, USA BOOK NOW! Key Speakers Ron Guido, Vice President of Global Brand Protection, Johnson & Johnson Ravi Kalyanaraman, Senior Scientist, Bristol-Myers Squibb Robert Celeste, Director, GS1 Healthcare US Julien Bradley, Director of Product Management and Marketing, Thermo Fisher Scientific Richard Halverson, Senior Special Agent and Chief of the Outreach and Training Unit, National Intellectual Property Rights Coordination Center Bonni Kirkwood, Senior Manager Strategy and Operations, Deloitte Consulting Wendell Smith, President, Technology Transfer Group Frank Schurgers, Managing Director, Integris International Joan Antokol, Managing Partner, Privacy and Data Protection Practice, Park Legal, LLC Teresa Anzalone, Trademark Attorney, Symbus Law Group Terrence Gaffney, Intellectual Property Practice Manager, Eckert Seamans, Cherin and Mellott, LLC Neville Broad, Technical Manager, Abbott Tom Woods, President, Woods International, LLC Senior Representative, TÜV International GmbH Organised By Driving the Industry Forward | www.futurepharmaus.comMedia PartnersTo Book Call: +44 (0) 20 7336 6100 |
  2. 2. Conference Introduction 2nd Pharmaceutical Anti-counterfeiting Americas November 14th - 15th, 2011, Boston, USA Dear Colleague, he FDA estimates counterfeit medicines to make up more than T Poster Presentation 10% of the global pharmaceutical market. Recently the US At a busy conference it is hard to make sure everyone government injected $3.36m into 15 projects aimed at combating who shares your interests knows what you are doing. counterfeit medicines in developing countries including several Maximise your time at Visiongain’s 2nd Pharmaceutical Latin American and African countries. The US President also has Anti-counterfeiting Americas meeting by sharing your plans to eradicate illegal internet pharmacies with the set-up results in a poster presentation. With a plethora of key of public-private partnership backed by commercial companies decision makers, take advantage of this senior networking including Google and Microsoft. opportunity. evenues of pharmaceutical counterfeit technologies are expected R Please send your 200 word abstract, in English, to: to rise considerably in the coming years as countries in the for approval. The deadline developed world step up their efforts to tackle the growing problem for submissions is Tuesday, November 1st, 2011. Please of fake medicines. include contact details for the corresponding author(s). aving organized 6 successful Pharmaceutical Anti-Counterfeiting H Academic institutions will not be charged a fee if booked as conferences in the past, Visiongain is now preparing for its full-price delegates. Posters submitted by pharmaceutical 2nd Pharmaceutical Anti-Counterfeiting Americas Conference. Our and biotechnology firms will be charged a fee of £199. featured line up of industry experts will discuss the global threat Posters submitted by service providers / vendors are welcome of counterfeit medicines and brainstorm how to best tackle the and will be subject to evaluation. Upon approval a fee of problem to ensure you are in a better position to secure your £500 will apply. Two delegates from your organisation products against counterfeiters. must be booked at full price to present a poster. Please note that all posters will be displayed at the Why you should attend this conference discretion of Visiongain Ltd and are subject to approval. Due to limited space, please register your interest early. • Hear the latest in US policy updates • Review current US legislative and regulatory infrastructures • Identify new technologies in track and trace packaging Who should attend this conference? • Explore the effects of parallel trade Chief Security Officers, VPs, directors, heads, managers • Debate the best practices in pharmaceutical supply chain integrity and specialists of: • Assess the effects of counterfeit drugs on drug manufacturers • Supply chain/ Supply Chain Security/ Supply Chain • Evaluate analytical methods for detection Systems/ Global Supply Chain • Understand the role of illegal internet pharmacies • Anti-counterfeit Projects / Anti-counterfeiting Operations • Use this as a platform to forge future business collaborations • Brand Protection I look forward to meeting you at the conference • Pharmaceutical and biotechnology companies Best regards • Security/ Global Security • Packaging suppliers • Wholesale & distribution • Quality Assurance/ Quality Control Koos Mohammed • Specialists in pharmaceutical logistics Conference Producer • Regulatory organisations and Law firms • Compliance
  3. 3. Day 1 2nd Pharmaceutical Anti-counterfeiting Americas Monday November 14th, 2011 09:00 Registration and refreshments 13:40 Developing regulatory agencies with teeth: how the international community can help 09:30 Opening address from the chair • egulatory agencies are on the front lines in the war against counterfeit R pharmaceuticals and must be trained and equipped to stay in the fight Ravi Kalyanaraman • apacity building, especially for less developed country regulatory C Senior Scientist agencies, will help strengthen international enforcement efforts and save Bristol-Myers Squibb thousands of lives • onor governments and institutions, working with the private sector, can D 09:40 Preparing for serialization and visibility within the substantially enhance global capacity to fight fake drugs U.S. pharmaceutical supply chain Tom Woods • Preparation for state drug pedigree requirements President • Product serialization implementation Woods International, LLC • Managing pedigree data • Connecting with trading partners 14:20 The challenges of investigating international pharmaceutical counterfeiting • Key learnings from the pilots to date • An investigator’s perspective Robert Celeste • Collaboration with national and international law enforcement agencies Director • The benefits of new technologies GS1 Healthcare US Frank Schurgers Managing Director 10:20 Analyzing the analytical techniques for counterfeit Integris International detection • Fingerprinting pharmaceutical products using several analytical techniques 15:00 Afternoon Refreshments • The various analytical techniques that are available - ros and cons for pharmaceutical product fingerprinting P 15:20 Forging partnerships to combat Ravi Kalyanaraman counterfeit medicines Senior Scientist • trategies for better partnership between regulators, law enforcers, S Bristol-Myers Squibb and industry • The need for greater discussion • Conducting market research in areas of high risk 11:00 Morning refreshments • The link between parallel trade and fake drugs entering the supply chain Bonni Kirkwood 11:20 Use of handheld Raman, FTIR, and NIR Senior Manager Strategy and Operations spectrometers for field screening of counterfeits Deloitte Consulting • Basics of vibrational spectroscopy for pharmaceutical anti-counterfeiting • ow technology advances are allowing lab-quality testing to be done H 16:00 The role of the pharmaceutical industry in in the field combating counterfeit medicines • ase study: implementation of handheld Raman instruments by C • Openness in reporting cases of counterfeit medicines Nigeria’s NAFDAC • Developing improved co-operation strategies Julien Bradley • Collaboration and international engagement Director of Product Management and Marketing Thermo Fisher Scientific 16:40 Closing remarks from the chair 12:00 Counterfeit drugs and drug safety implications 16:50 Networking drinks • bligations relating to adverse event reporting in the context of O counterfeit drugs Take your discussions further and build new • Implications for your product – and for patient safety relationships in a relaxed and informal setting. • Examples of the challenges • Tips and recommendations for minimizing your risks N Joan Antokol EW Partner Pharma Business Daily SL Park Legal LLC ET TE Each issue of Pharma Business Daily newsletter focuses on R latest breaking stories in your market. Delivered directly to 12:40 Networking lunch your Inbox or available through the website, all the industry news is available to you all the time. When you want the news its there for you - it really is that simple. Over 25+ stories everyday as they happen. Never again will any of your colleagues be aware of news that you aren’t. Plus exclusive features from visiongain conferences and in-depth analysis from visiongain analysts will be available to you thanks to your subscription to PharmaBusinessDaily. This information is not available anywhere else. Call +44 (0)207 336 6100 or visit to sign up. Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2011
  4. 4. Day 2 2nd Pharmaceutical Anti-counterfeiting Americas Tuesday November 15th, 2011 09:00 Registration and refreshments 13:20 Anti-Counterfeiting in the pharmaceutical industry from the IP professional’s perspective: the need for a 09:30 Opening address from the chair multifaceted and collaborative approach • trademark registration program A Richard Halverson Senior Special Agent and Chief of the Outreach and Training Unit • customs recordal program (including visits to customs officials) A National Intellectual Property Rights Coordination Center • copyright registration program A • n internet monitoring program to identify mis-use of IP by third parties A 09:40 Pharmaceuticals, counterfeits and the internet • cooperative and coordinated approach to problem solving involving in- A • PR’s undercover operation targeting persons and organizations exploiting I house IP counsel, external law firms, customs, regulatory personnel, FDA, the internet investigators, law enforcement and others • Why counterfeiting is no longer a harmless crime Teresa Hechmer Anzalone • The impact of counterfeiting on businesses and the public Trademark Attorney Symbus Law Group Richard Halverson Senior Special Agent and Chief of the Outreach and Training Unit National Intellectual Property Rights Coordination Center 14:00 Legal arsenals to combat pharmaceutical counterfeit drugs: where do you take the fight? • Legal definition of counterfeits 10:20 Securing the pharmaceuticals supply chain: the challenges and solutions of brand protection • The problems • manufacturer’s perspective: safe & secure supply chain best practices A • WHO leads the global effort to combat counterfeits • pplication of anti-counterfeiting technologies - are they effective? A • Illegal diversion • hat does the future of brand protection look like? W • Pharmaceutical theft • Identifying individuals responsible for illegal online activities Ron Guido Vice President of Global Brand Protection Terrence Gaffney Johnson & Johnson Intellectual Property Practice Manager Eckert Seamans, Cherin and Mellott, LLC 11:00 Morning refreshments 14:40 Afternoon refreshments 11:20 Presentation to be announced 15:00 The use of X-ray Fluorescence (XRF) for Senior Representative TÜV International GmbH Pharmaceutical Anti-Counterfeiting • Analysis of counterfeit capsule blend using non-destructive XRF 11:40 What’s new technically? • How XRF elemental analysis compliments established portable techniques • omputer generated holograms C • Combing data from rapid technologies for enhanced intelligence • n press embossing O Neville Broad • o copy inks N Technical Manager Abbott • nique flourescent dyes U • NA molecular taggants D 15:00 How parallel trade is contributing to Wendell Smith counterfeit drugs President • he link between parallel trade and fake drugs entering the supply chain T Technology Transfer Group • look at the regulatory environment A 12:20 Networking lunch • trategies for improving the supply chain S 16:20 Chair’s closing remarks 16:30 End of Conference N EW Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021 RE PO What are the commercial prospects for pharmaceutical anti-counterfeiting technology? Our new report shows you that RT industry and market’s revenue potential from 2011 to 2021. Our report shows you revenue prospects for pharma anti- counterfeiting technologies at total world, submarket and national levels to 2021. We discuss the anti-counterfeiting activities of companies such as Pfizer, J&J, GSK, Sanofi-Aventis, Novartis and AstraZeneca.
  5. 5. Partners 2nd Pharmaceutical Anti-counterfeiting Americas November 14th - 15th, 2011, Boston, USA Media Partners: Sponsorship and exhibition opportunities: is the leading industry-sponsored This event offers a unique opportunity to meet and do business with portal for the pharmaceutical sector. Supported by most some of the key players in the pharmaceutical and biotech industries. of the leading pharmaceutical corporations, provides If you have a service or product to promote, you can do so at this dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. event by: For further information please email: • Hosting a networking drinks reception • Taking an exhibition space at the conference BIOTECHNOLOGY EUROPE is owned by • Advertising in the delegate documentation pack BIOTECHNOLOGY WORLD. It is based and located • Providing branded bags, pens, gifts, etc. in Warsaw, Poland. Biotechnology World was founded in 2007 to If you would like more information on the range of provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business sponsorship or exhibition possibilities for visiongains 2nd processes. Its first step to fulfilling that mission was building the Pharmaceutical Anti-counterfeiting Americas Conference, BIOTECHNOLOGY EUROPE platform that will allow a quick please contact us. spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, Piyush Patel, +44 (0)20 7549 9961 publication and marketing solutions. One of the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit About visiongain: Visiongain is a specialist business information company focused on InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, providing cutting edge products and services across the Pharmaceutical/ jobs and events and is home to, Pharmafile and Biotech, Telecommunications, Defence and Finance sectors, which Pharmafocus. include reports, conferences, online daily news and offline news For further information please visit: analysis and bespoke consultancy. With a commitment to innovation and excellence, visiongain offers flexible solutions to meet our clients’ Future Pharmaceuticals has forged powerful Driving the Industry Forward | relationships with key industry leaders to provide a business intelligence needs, providing the right information at the platform for successful brand recognition, and for senior decision- right time to facilitate the commercial decision-making process. Our makers to have the means to procure and plan implementation pharmaceutical products include Pharma Business Daily, the leading strategies based on the topics covered. Positioned to be an daily email newsletter for the pharmaceutical, biotech and healthcare authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine industries, and a range of independent, high-quality, in-depth reports is geared to create a deep penetration into a highly targeted and covering focused and topical areas of concern. Our pharmaceutical responsive audience, bridging the gap between the industries’ top conferences address the hottest commercial, regulatory and technical issues and the solutions top-tier vendors can provide. For further information please visit: topics and provide an ideal forum for debate and networking for pharmaceutical professionals from around the world. For further information, please visit:
  6. 6. Registration Form 2nd Pharmaceutical Anti-counterfeiting Americas November 14th - 15th, 2011, Boston, USA For multiple bookings Photocopy this form Conf. code PP Pharmaceutical Anti- Standard Prices counterfeiting Americas Conference only Fee: £1299 (USD* 2113) November 14th – 15th, 2011 *USD price is estimate only Boston, USA Promotional Literature Distribution Distribution of your company’s promotional literature to all conference attendees Fee: £999 VAT: £199.80 Total: £1198.80 How to book Details Email: Web: Forename: Surname: UK Office: Tel: +44(0) 20 7549 9961 Job Title: Company: Fax: +44(0) 20 7549 9932 Visiongain Ltd Main Switchboard Number: 230 City Road London Address: EC1V 2QY UK General information Venue: Country: Postcode: Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee Phone: Fax: may be requested if payment has not been received in full before the event. Visiongain Ltd reserves the right to charge interest on unpaid invoices. Email: Substitutions/name changes or cancellations: There is a 50% liability on all bookings once made, whether by post, fax, email or web. There is a no refund policy for cancellations received on or Signature: after one month before the start of the event. Should you decide to cancel after this date, the full invoice must be paid. Conference notes will then be sent to you. Unfortunately, we are unable to transfer places I confirm that I have read and agree to the terms and conditions of booking between conferences. However, if you cannot attend the conference, you may make a substitution/name change at any time, as long as we are informed in writing by email, fax or post. Name changes and substitutions must be from the same company or organisation and are not transferable between Methods of payment countries. Please note that discounted delegates places at a visiongain event are non refundable. Payment must be made in sterling Invoice alterations: There will be an administration charge of £50 for any changes to an invoice, excluding substitutions/name changes, requested by the customer. This will be charged to the By Mail: Complete and return your signed registration form together with your cheque payable customer by credit card prior to the changes being made. to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled By Fax: Complete and fax your signed registration form with your credit card details due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try to +44 (0) 20 7549 9932 to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or expenses, which may be incurred by the customer as a consequence of the event being postponed or By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the cost of the registration, travel and expenses. By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data By Bank Transfer: Protection Act 1988. Your personal information contained in this form may be used to update you on visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We Visiongain Ltd A/C: visiongain Ltd may also share your data with external companies offering complementary products or services. If you Barclays Bank Sort Code: 20-71-64 wish for your details to be amended, suppressed or not passed on to any external third party, please send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London, Piccadilly Branch Account No: 6038 7118 EC1V 2QY. Alternatively, you can visit our website at and amend your details. 48 Regent Street Swift Code: BARC GB22 Please allow approximately 30 days for your removal or update request to be applied to our database. London W1B 5RA, UK IBAN: GB80 BARC 20716460387118 Following your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes are coming into effect. Please debit my credit card: Fee: The conference fee includes lunch, refreshments and conference papers provided on the day. Access MasterCard Visa American Express This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain). VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, Card number: Eurocash specialise in recovering cross-border VAT. How we will contact you: Visiongain Ltd’s preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you. Expiry Date: Unable to attend Security number (last 3 digits on back of credit card): Obviously nothing compares to being there but you need not miss out. Simply tick the box and send with your payment. You will receive speaker talks in PDFs two weeks after the event. Signature: Yes, please send me speaker talks Price£550 VAT:£110 Total:£660 Cardholder’s name: Office use only News updates Please tick if you do not want to receive email news updates in the future